Edwards Lifesciences Corp (EW) income statement
EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3056% above fair value
$101.85−2.03 (-1.95%)
Close on Nov 20, 2026Market cap $58.71BP/E 58.5Yield –
Edwards Lifesciences Corp financial ratios
See a number that looks wrong?